Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:07 PM
Ignite Modification Date:
2025-12-24 @ 4:07 PM
NCT ID:
NCT02991066
Eligibility Criteria:
Inclusion Criteria:
* Patients with de novo APL accompanied by hemorrhage.
* The diagnosis was confirmed by the presence of t(15;17) and/or the PML (promyelocytic leukemia)/RARa(retinoic acid receptor alpha) fusion gene.
* Patients should receive single-agent arsenic trioxide (ATO) for induction therapy.
Exclusion Criteria:
* Patients with relapsed acute promyelocytic leukemia.
* Patients without evidence of bleeding.
* Patients younger than 18 years.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02991066
Study Brief:
Protocol Section:
NCT02991066